Helps match cancer patients to clinical trials using screening
Part of Cancer clinical trials.
This study screens certain cancer types and collects a sample to check it’s good enough for future trial matching and research. If you qualify, your care team may use your sample to help find the most efficient clinical trial options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed cancer tumor type the study is looking for (at the hospital or confirmed centrally).
- You can provide an approved biological sample (like blood or tissue) for research use.
- The study team can confirm your sample has enough amount and quality for follow-up testing.
- You are age 12 or older.
- You don’t have personal, family, social, or location situations that would make follow-up appointments hard to keep.
- You (or a legal guardian) can give written informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses an AI system to help match people with certain cancer types and specific tumor test results (like gene or protein markers) to relevant clinical trials. It may help you and your doctor find studies that fit your cancer biology faster.
This study uses advanced DNA testing on tumor samples to help match cancer treatments more precisely. It may help researchers learn which cancer changes are driving your tumor and how they relate to treatment choices.
This study looks at your tumor’s genetic information to help doctors recommend treatment for cancers that have spread. It may help you get the most suitable therapy based on what’s found in your tumor.
This research program studies solid tumors to find better treatments. It collects health data to help develop personalized cancer care.
This study uses advanced testing (molecular profiling and imaging) to better understand cancers and help guide treatment. It is for people with certain advanced cancers who have not yet had immunotherapy or targeted therapy.
This study collects samples (like tissue biopsies and imaging information) from people with certain cancers who are starting anti–PD-1/PD-L1 immunotherapy. It helps researchers gather material to study how these treatments work.
Hear when a new All Tumor Types trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.